Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-08

Clinical Trial Update: Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia With uFSH [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the effectiveness and safety of uFSH for men with severe oligospermia or azoospermia. The sponsor is Livzon Pharmaceutica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • uFSH (urinary follicle-stimulating hormone)

Snippet

Sponsor: Livzon Pharmaceutical Group Inc. | Conditions: Oligospermia, Azoospermia | Phase 4 | Status: UNKNOWN